• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

RIG-I and TLR4 Responses and Adverse Outcomes in Pediatric Influenza-Related Critical Illness

tetano

Editor, Senior Moderator
J Allergy Clin Immunol. 2020 Feb 5. pii: S0091-6749(20)30179-2. doi: 10.1016/j.jaci.2020.01.040. [Epub ahead of print] [h=1]RIG-I and TLR4 Responses and Adverse Outcomes in Pediatric Influenza-Related Critical Illness.[/h]
Novak T[SUP]1[/SUP], Hall MW[SUP]2[/SUP], McDonald DR[SUP]3[/SUP], Newhams MM[SUP]4[/SUP], Mistry AJ[SUP]4[/SUP], Panoskaltsis-Mortari A[SUP]5[/SUP], Mourani PM[SUP]6[/SUP], Loftis LL[SUP]7[/SUP], Weiss SL[SUP]8[/SUP], Tarquinio KM[SUP]9[/SUP], Markovitz B[SUP]10[/SUP], Hartman ME[SUP]11[/SUP], Schwarz A[SUP]12[/SUP], Junger WG[SUP]13[/SUP], Randolph AG[SUP]14[/SUP]; PALISI Pediatric Intensive Care Influenza (PICFLU) Network Investigators.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Decreased tumor necrosis factor (TNF)-α production in whole blood following ex vivo lipopolysaccharide (LPS) stimulation indicates suppression of the toll-like receptor (TLR)4 pathway. This is associated with increased mortality in pediatric influenza critical illness. Whether anti-viral immune signaling pathways are also suppressed in these patients is unclear.
[h=4]OBJECTIVES:[/h] We evaluated suppression of the TLR4 and the anti-viral retinoic acid-inducible gene-I (RIG-I) pathways with clinical outcomes in children with severe influenza infection.
[h=4]METHODS:[/h] In this 24-center, prospective, observational cohort study of children with confirmed influenza infection, blood was collected within 72 hours of intensive care unit admission. Ex vivo whole blood stimulations were performed with matched controls using the viral ligand, polyinosinic-polycytidylic acid (poly(I:C))-low molecular weight/LyoVec[SUP]TM[/SUP] and LPS to evaluate interferon (IFN)-α and TNF-α production capacities (RIG-I and TLR4 pathways, respectively).
[h=4]RESULTS:[/h] Suppression of either IFNα or TNFα production capacity was associated with longer duration of mechanical ventilation and hospitalization, and increased organ dysfunction. Children with suppression of both RIG-I and TLR4 pathways (n=33/103, 32%) were more likely to have prolonged (≥7 days) multiple organ dysfunction syndrome (30.3% vs 8.6%, p=0.004) or prolonged hypoxic respiratory failure (39.4% vs 11.4% p=0.001) compared to those with single- or no pathway suppression.
[h=4]CONCLUSIONS:[/h] Suppression of both RIG-I and TLR4 signaling pathways, essential for respective anti-viral and anti-bacterial pathogens responses, is common in previously immunocompetent children with influenza-related critical illness and is associated with bacterial co-infection and adverse outcomes. Prospective testing of both pathways may aid in risk-stratification and in immune monitoring.
Copyright ? 2020. Published by Elsevier Inc.


[h=4]KEYWORDS:[/h] critical care; influenza; interferon alpha; lipopolysaccharide; pediatric; polyinosinic:polycytidylic acid; retinoic acid-inducible gene-I; suppression; toll-like receptor 4; tumor necrosis factor alpha

PMID: 32035159 DOI: 10.1016/j.jaci.2020.01.040
 
Back
Top Bottom